XGN
EXAGEN INC.
Next earnings Jul 27, 2026 · consensus $-0.19 EPS, $18.0M rev
Last earnings +34.9% on 2026-05-11
$4.57
▼ -1.51%$4.57▼ -34.43%
over 1Y
L $2.65EODHDH $11.96
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.5%
1W+3.6%
1M-8.6%
3M+70.9%
YTD-24.2%
1Y-34.3%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Revenue grew 19.7% YoY; but unprofitable (net margin -30.0%).
Revenue (FY2025) $66.6M · FY2025
EXAGEN INC. shows $66.6M in FY2025 revenue (+19.7% YoY), a -30.0% net margin, and -114.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $48.3M | $45.6M | $52.5M | $55.6M | $66.6M |
| Gross profit | — | — | $29.5M | $33.1M | $38.8M |
| Operating income | -$24.1M | -$46.1M | -$22.8M | -$13.6M | -$14.1M |
| Net income | -$26.9M | -$47.4M | -$23.7M | -$15.1M | -$20.0M |
| Diluted EPS | -$1.68 | -$2.77 | -$1.34 | -$0.83 | -$0.93 |
| Net margin | -55.6% | -104.0% | -45.1% | -27.2% | -30.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$101M
EV / EBITDA—
EV / Sales1.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-18.2%
FCF yield-13.0%
Quality & risk
ROIC (est.)-27.5%
Free cash flow-$14.3M
Total debt$22.9M
Net cash$9.31M
Altman Z-Score-4.89 distress
Piotroski F-Score3/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+34.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-092026-06-22open ↗4Period ending 2026-06-092026-06-22open ↗4Period ending 2026-06-092026-06-22open ↗8-KPeriod ending 2026-06-092026-06-09open ↗SCHEDULE 13GFiling2026-05-27open ↗SCHEDULE 13G/AFiling2026-05-20open ↗S-8Filing2026-05-12open ↗10-QPeriod ending 2026-03-312026-05-11open ↗8-KPeriod ending 2026-05-112026-05-11open ↗ARSPeriod ending 2025-12-312026-04-27open ↗DEFA14AFiling2026-04-27open ↗DEF 14APeriod ending 2026-06-092026-04-27open ↗
Frequently asked
- Is EXAGEN INC. (XGN) a buy?
- XGN currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 19.7% YoY; but unprofitable (net margin -30.0%).
- What is EXAGEN INC.'s quality score?
- XGN scores 49.98039215686274/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001274737, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 7:28:10 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.